These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1921758)

  • 1. Characterization of two bacteriocins produced by Clostridium perfringens.
    Higa A; Yoshida E; Miyoshi Y
    Microbiol Immunol; 1991; 35(6):411-21. PubMed ID: 1921758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Purification and characterization of "Clostridium perfringens" BP6K-N5 strain bacteriocin N5 (author's transl)].
    Wolff A; Ionesco H
    Ann Microbiol (Paris); 1975; 126(3):343-56. PubMed ID: 174471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of bacteriocin 28 produced by Clostridium perfringens.
    Li AW; Verpoorte JA; Lewis RG; Mahony DE
    Can J Microbiol; 1982 Jul; 28(7):860-73. PubMed ID: 6293695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of neuraminidase from Clostridium perfringens.
    Chien CH; Chang SC; Wei YH
    Proc Natl Sci Counc Repub China B; 1989 Jul; 13(3):201-9. PubMed ID: 2556722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and partial characterization of a bacteriocin isolated from Bacteroides ovatus H47.
    Miranda CM; Farias LM; Carvalho MA; Damasceno CA; Totola AH; Tavares CA; Cisalpino EO; Vieira EC
    Can J Microbiol; 1993 Feb; 39(2):169-74. PubMed ID: 8467417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and partial characterization of a bacteriocin produced by an oral Fusobacterium nucleatum isolate.
    Ribeiro-Ribas RN; de Carvalho MA; Vieira CA; Apolônio AC; Magalhães PP; Mendes EN; Oliveira JS; Santoro MM; Farias Lde M
    J Appl Microbiol; 2009 Aug; 107(2):699-705. PubMed ID: 19426276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruminococcin C, a new anti-Clostridium perfringens bacteriocin produced in the gut by the commensal bacterium Ruminococcus gnavus E1.
    Crost EH; Ajandouz EH; Villard C; Geraert PA; Puigserver A; Fons M
    Biochimie; 2011 Sep; 93(9):1487-94. PubMed ID: 21586310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriocin susceptibility of Clostridium perfringens: a provisional typing schema.
    Mahony DE
    Appl Microbiol; 1974 Aug; 28(2):172-6. PubMed ID: 4368445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of two bacteriocins produced by Pediococcus acidilactici isolated from "Alheira", a fermented sausage traditionally produced in Portugal.
    Albano H; Todorov SD; van Reenen CA; Hogg T; Dicks LM; Teixeira P
    Int J Food Microbiol; 2007 May; 116(2):239-47. PubMed ID: 17368595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium perfringens--specific lysin.
    Nakamura S; Okada I; Mizuno J; Nishida S
    Can J Microbiol; 1977 May; 23(5):601-6. PubMed ID: 17459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of a bacteriocin from Klebsiella pneumoniae 158.
    Chhibber S; Vadehra DV
    J Gen Microbiol; 1986 Apr; 132(4):1051-4. PubMed ID: 3531394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of a Corynebacterium ulcerans bacteriocin (ulceracin 378).
    Abrehem K; Zamiri I
    J Gen Microbiol; 1985 Apr; 131(4):707-13. PubMed ID: 3921657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of Clostridium perfringens and its L form to bacteriocins of C. perfringens.
    Mahony DE
    Can J Microbiol; 1982 Sep; 28(9):1032-6. PubMed ID: 6291734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary characterization of inhibitors of Neisseria gonorrhoeae produced in vitro by Eubacterium limosum.
    Morin A; Bisaillon JG; Beaudet R; Sylvestre M; Saheb SA; Leduc D
    Can J Microbiol; 1984 Feb; 30(2):251-9. PubMed ID: 6424921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The assessment and application of a bacteriocin typing scheme for Clostridium perfringens.
    Watson GN
    J Hyg (Lond); 1985 Feb; 94(1):69-79. PubMed ID: 2857743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of the phosphofructokinase regulatory factors.
    Kruep DA; Dunaway GA
    Arch Biochem Biophys; 1984 Dec; 235(2):504-11. PubMed ID: 6240226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and partial characterization of a bacteriocin from Serratia marcescens.
    Foulds J
    J Bacteriol; 1972 Jun; 110(3):1001-9. PubMed ID: 4555400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of the Lactobacillus acidophilus bacteriocin lactacin B.
    Barefoot SF; Klaenhammer TR
    Antimicrob Agents Chemother; 1984 Sep; 26(3):328-34. PubMed ID: 6439113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theta-toxin of Clostridium perfringens. I. Purification and some properties.
    Yamakawa Y; Ito A; Sato H
    Biochim Biophys Acta; 1977 Oct; 494(2):301-13. PubMed ID: 199270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and properties of beta-fructofuranosidase from Clostridium perfringens.
    Ishimoto M; Nakamura A
    Biosci Biotechnol Biochem; 1997 Apr; 61(4):599-603. PubMed ID: 9145517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.